1. World Health Organization: World Malaria Report 2012. 2012, [cited 2013 March, 17th]; Available from:
http://www.who.int/malaria/publications/world_malaria_report_2012/en/
2. United Nations Human Rights Council: Access to medicines in the context of the right of everyone to the to the enjoyment of the highest attainable standard of physical and mental health. Twenty-third session, Agenda item 3, Promotion and protection of all human rights, civil, political, economic, social and cultural rights, including the right to development 2013 [cited 2013 June 20th]; Available from:
http://ap.ohchr.org/documents/dpage_e.aspx?si=A/HRC/23/L.10/rev.1
3. Caudron JM, Ford N, Henkens M, Macé C, Kiddle-Monroe R, Pinel J: Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Médicaments sous-standard dans les milieux défavorisés: un problème qui ne peut plus être ignoré. Revue Medicamentos sub-estándar en lugares con pocos recursos: un problema que no puede ser ignorado por más tiempo. Revisión. Tropical Med Int Health. 2008, 13 (8): 1062-1072. 10.1111/j.1365-3156.2008.02106.x.
4. Institute of Medicine of the National Academies: Countering the Problem of Falsified and Substandard Drugs. 2013, National Academy of Sciences. The National Academies Press, Available from:
http://www.iom.edu/reports/2013/countering-the-problem-of-falsified-and-substandard-drugs.aspx
5. Newton PN, Green MD, Mildenhall DC, Plancon A, Nettey H, Nyadong L, Hostetler DM, Swamidoss I, Harris GA, Powell K, Timmermans AE, Amin AA, Opuni SK, Barbereau S, Faurant C, Soong RCW, Faure K, Thevanayagam J, Fernandes P, Kaur H, Angus B, Stepniewska K, Guerin PJ, Fernandez FM: Poor quality vital antimalarials in Africa – an urgent neglected public health priority. Malar J. 2011, 10: 352-10.1186/1475-2875-10-352.